|
|
 |
|
Viewing report
|
|
|
|
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc, Aug 2011, Pages: 433
This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 50 companies including many key and niche players such as Abbott Laboratories, Alimentary Health Limited, Edusa Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Lexicon Pharmaceuticals, Pharmos Corporation, Salix Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., and Tioga Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
|
|
|
|
